The best thing I heard from the AGM is that the FDA studies will only cost $20-40 million USD, which is less than I expected. Plus we will get paid for those valves and if we do 350 patients (my guess) at a reimbursement of $25,000 per valve, that would bring in $8.75 million.
I should have finished watching the AGM before my last post but the SAVR study in Belgium was stopped because of covid and those results will be published later this year, so that's something to look forward to. Also, Dr Meuris who was running the SAVR study in Belgium will switch to working on the TAVR study.
And thanks for posting the link to the vid Eire. Appreciate all the work you do here.
AVR Price at posting:
$23.42 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)